Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Receiver Operating Characteristic Plot01:15

Receiver Operating Characteristic Plot

352
A ROC (Receiver Operating Characteristic) plot is a graphical tool used to assess the performance of a binary classification model by illustrating the trade-off between sensitivity (true positive rate) and specificity (false positive rate). By plotting sensitivity against 1 - specificity across various threshold settings, the ROC curve shows how well the model distinguishes between classes, with a curve closer to the top-left corner indicating a more accurate model. The area under the ROC curve...
352
Sensitivity, Specificity, and Predicted Value01:13

Sensitivity, Specificity, and Predicted Value

806
In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
806
Odds Ratio01:09

Odds Ratio

386
The odds ratio (OR) is a statistical measure used extensively in epidemiology and research to quantify the strength of association between exposure and outcome across different groups. Unlike relative risk, which compares the probabilities of an event occurring, the odds ratio compares the odds of an event occurring in the exposed group to the odds of it occurring in the unexposed group. The odds, in this context, are calculated as the probability of the event happening divided by the...
386
Relative Risk01:12

Relative Risk

529
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
529
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

200
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
200
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

343
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
343

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Investigational clinical trial agents versus conventional second salvage therapies in patients with relapsed/refractory acute myeloid leukemia.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE).

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Longitudinal Modeling of Rank-based Global Outcome.

Statistica Sinica·2026
Same author

Addressing nonignorable missing data and heterogeneity in prognostic biomarker assessment.

Statistical methods in medical research·2026
Same author

Rejoinder to reader reaction "Comment on 'Double robust conditional independence test for novel biomarkers given established risk factors with survival data' by Lucas Kook".

Biometrics·2026
Same author

The Time-Dependent Association Between Irritable Bowel Syndrome and All-Cause and Cause-Specific Mortality in the NIH-AARP Cohort Study.

The American journal of gastroenterology·2026

Related Experiment Video

Updated: Oct 15, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K

Evaluation of competing risks prediction models using polytomous discrimination index.

Maomao Ding1, Jing Ning2, Ruosha Li3

  • 1Department of Statistics, Rice University, Houston, TX 77005, U.S.A.

The Canadian Journal of Statistics = Revue Canadienne De Statistique
|October 28, 2021
PubMed
Summary

We developed a new method to evaluate prediction models for patients with competing risks data, accounting for informative censoring. This approach accurately measures how well models distinguish between different patient outcomes.

Keywords:
Competing risksFine & Gray modelcumulative incidencepolytomous discrimination indexpredictive discriminationprognostic model

More Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.4K
Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

1.1K

Related Experiment Videos

Last Updated: Oct 15, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.4K
Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

1.1K

Area of Science:

  • Biostatistics
  • Medical Statistics
  • Survival Analysis

Background:

  • Predicting patient outcomes with competing risks data is crucial.
  • Informative censoring in competing risks data complicates outcome prediction.
  • Existing methods may not adequately assess prediction model performance.

Purpose of the Study:

  • To propose a novel estimator for the polytomous discrimination index for competing risks data.
  • To quantify the discriminatory ability of prognostic models in the presence of competing risks.
  • To develop an efficient computational algorithm and robust variance estimation for the proposed index.

Main Methods:

  • Developed an estimator for the polytomous discrimination index applicable to competing risks.
  • Proposed an efficient computation algorithm with O(n log n) complexity.
  • Utilized a perturbation resampling scheme for consistent variance estimation.

Main Results:

  • The proposed estimator is robust to model misspecification and possesses desirable asymptotic properties.
  • Numerical simulations indicate good performance in realistic sample sizes.
  • The method was successfully applied to a study on monoclonal gammopathy of undetermined significance.

Conclusions:

  • The novel polytomous discrimination index estimator provides a reliable tool for assessing prediction models in competing risks scenarios.
  • The efficient algorithm and variance estimation enhance the practical utility of the proposed method.
  • This work contributes to improved prognostic modeling in clinical research involving competing risks.